Related Experiment Videos
Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2)
D J McQuillan1, M D Richardson, J F Bateman
1Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.
Bone
|April 1, 1995
Summary
This study defines procollagen and proteoglycan biosynthesis in SAOS-2 cells, revealing their ability to form a mineralizable collagenous matrix and secrete specific proteoglycans, crucial for bone matrix development.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedics
Background:
- SAOS-2 cells can maintain an osteoblast phenotype in long-term culture.
- Ascorbic acid supports the maintenance of this phenotype and matrix deposition.
Purpose of the Study:
- To define procollagen and proteoglycan biosynthesis in SAOS-2 cells.
- To investigate matrix formation and mineralization in a human osteogenic sarcoma cell line.
Main Methods:
- Long-term culture of SAOS-2 cells with ascorbic acid.
- Biosynthetic labeling with [35S]sulfate and [3H]glucosamine.
- Northern blot hybridization for gene expression analysis.
Main Results:
- SAOS-2 cells deposited a mineralizable collagenous matrix (collagen type I and V).
- Two major proteoglycans, CSPG and decorin, were identified.
- Proteoglycan secretion patterns differed between non-mineralizing and mineralizing cultures.
- SAOS-2 cells express mRNA for bone-related proteins like decorin, osteonectin, and bone sialoprotein.
Conclusions:
- SAOS-2 cells provide a model for studying osteoblast matrix production and mineralization.
- Proteoglycan synthesis and secretion are regulated during matrix mineralization.
- The expression of key bone matrix proteins is confirmed in this cell line.